Losmapimod Safety and Efficacy in COVID-19

NCT04511819 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
52
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated due to the rapidly evolving environment for the treatment of Covid-19 and ongoing challenges to identify and enroll qualified patients to participate.

Conditions

Interventions

Sponsor

Fulcrum Therapeutics